Inventiva S.A. (IVA)
NASDAQ: IVA · Real-Time Price · USD
4.250
-0.230 (-5.13%)
At close: Aug 3, 2026, 4:00 PM EDT
4.250
0.00 (0.00%)
Pre-market: Aug 4, 2026, 4:57 AM EDT
Inventiva Market Cap
Inventiva has a market cap or net worth of $1.03 billion as of August 4, 2026. Its market cap has increased by 130.35% in one year.
Market Cap
1.03B
Enterprise Value
1.18B
1-Year Change
130.35%
Ranking
Category
Stock Price
$4.25
ChartMarket Cap Chart
Since July 10, 2020, Inventiva's market cap has increased from $547.96M to $1.03B, an increase of 88.04%. That is a compound annual growth rate of 10.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 1.03B | 16.45% |
| Dec 31, 2025 | 884.84M | 309.83% |
| Dec 31, 2024 | 215.91M | -7.64% |
| Dec 29, 2023 | 233.77M | 16.05% |
| Dec 30, 2022 | 201.44M | -63.07% |
| Dec 31, 2021 | 545.53M | -0.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Seaport Therapeutics | 1.10B |
| MeiraGTx Holdings | 1.09B |
| Wave Life Sciences | 1.09B |
| Alpha Tau Medical | 1.06B |
| Alto Neuroscience | 1.05B |
| EyePoint | 1.03B |
| Lexicon Pharmaceuticals | 1.03B |
| Cullinan Therapeutics | 1.01B |